China vs Egypt: Number of new G2D leprosy cases
China
60
in 2024
Egypt
88
in 2024
China rank
20th
Egypt rank
18th
Number of new G2D leprosy cases over time
- China
- Egypt
How they compare
Egypt currently reports 88 against 60 in China, a difference of 28.
That makes Egypt's figure about 1.5 times China's.
The two have swapped places 1 time across 12 shared years of data; in 2012 it was China ahead.
China ranks 20th and Egypt ranks 18th of 161 countries.
China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 158.71 | 49 | 109.71 | China |
| 2020s | 67.2 | 57 | 10.2 | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of new g2d leprosy cases, China or Egypt?
- Egypt, at 88 against 60 in China as of 2024.
- What is the difference in number of new g2d leprosy cases between China and Egypt?
- 28, with Egypt ahead.
- How many years of comparable data are there for China and Egypt?
- 12 years are reported by both, from 2012 to 2024.
- How do China and Egypt rank globally for number of new g2d leprosy cases?
- China ranks 20th and Egypt ranks 18th of 161 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of new G2D leprosy cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.